These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 12018407

  • 1. Does inhibition of Trypanosoma cruzi key enzymes affect parasite life cycle and geographic distribution?
    Salvati L, Bolognesi M, Ascenzi P.
    IUBMB Life; 2002 Jan; 53(1):45-7. PubMed ID: 12018407
    [Abstract] [Full Text] [Related]

  • 2. Multilocus polymerase chain reaction restriction fragment--length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): taxonomic and clinical applications.
    Rozas M, De Doncker S, Adaui V, Coronado X, Barnabé C, Tibyarenc M, Solari A, Dujardin JC.
    J Infect Dis; 2007 May 01; 195(9):1381-8. PubMed ID: 17397011
    [Abstract] [Full Text] [Related]

  • 3. Origins of Chagas disease: Didelphis species are natural hosts of Trypanosoma cruzi I and armadillos hosts of Trypanosoma cruzi II, including hybrids.
    Yeo M, Acosta N, Llewellyn M, Sánchez H, Adamson S, Miles GA, López E, González N, Patterson JS, Gaunt MW, de Arias AR, Miles MA.
    Int J Parasitol; 2005 Feb 01; 35(2):225-33. PubMed ID: 15710443
    [Abstract] [Full Text] [Related]

  • 4. An agent-based model for predicting the prevalence of Trypanosoma cruzi I and II in their host and vector populations.
    Devillers H, Lobry JR, Menu F.
    J Theor Biol; 2008 Dec 07; 255(3):307-15. PubMed ID: 18805428
    [Abstract] [Full Text] [Related]

  • 5. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM, Oliveira P, Mortara RA, Silveira JF, Bahia D.
    N Biotechnol; 2010 Dec 31; 27(6):837-43. PubMed ID: 20172059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trypanosoma cruzi, etiological agent of Chagas disease, is virulent to its triatomine vector Rhodnius prolixus in a temperature-dependent manner.
    Elliot SL, Rodrigues Jde O, Lorenzo MG, Martins-Filho OA, Guarneri AA.
    PLoS Negl Trop Dis; 2015 Mar 31; 9(3):e0003646. PubMed ID: 25793495
    [Abstract] [Full Text] [Related]

  • 9. Trypanosoma cruzi surface mucins: host-dependent coat diversity.
    Buscaglia CA, Campo VA, Frasch AC, Di Noia JM.
    Nat Rev Microbiol; 2006 Mar 31; 4(3):229-36. PubMed ID: 16489349
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quantitative proteomics of Trypanosoma cruzi during metacyclogenesis.
    de Godoy LM, Marchini FK, Pavoni DP, Rampazzo Rde C, Probst CM, Goldenberg S, Krieger MA.
    Proteomics; 2012 Aug 31; 12(17):2694-703. PubMed ID: 22761176
    [Abstract] [Full Text] [Related]

  • 14. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
    Agustí R, París G, Ratier L, Frasch AC, de Lederkremer RM.
    Glycobiology; 2004 Jul 31; 14(7):659-70. PubMed ID: 15070857
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of Mepraia spinolai and Triatoma infestans to different Trypanosoma cruzi strains from naturally infected rodent hosts.
    Campos R, Acuña-Retamar M, Botto-Mahan C, Ortiz S, Cattan PE, Solari A.
    Acta Trop; 2007 Oct 31; 104(1):25-9. PubMed ID: 17904090
    [Abstract] [Full Text] [Related]

  • 16. Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease?
    Piñeyro MD, Parodi-Talice A, Arcari T, Robello C.
    Gene; 2008 Jan 31; 408(1-2):45-50. PubMed ID: 18022330
    [Abstract] [Full Text] [Related]

  • 17. Trypanosoma cruzi: isoenzyme analysis suggests the presence of an active Chagas sylvatic cycle of recent origin in Paraná State, Brazil.
    Thomaz Soccol V, Barnabe C, Castro E, Luz E, Tibayrenc M.
    Exp Parasitol; 2002 Feb 31; 100(2):81-6. PubMed ID: 12054697
    [Abstract] [Full Text] [Related]

  • 18. Biochemical properties of Trypanosoma cruzi telomerase.
    Muñoz DP, Collins K.
    Nucleic Acids Res; 2004 Feb 31; 32(17):5214-22. PubMed ID: 15459291
    [Abstract] [Full Text] [Related]

  • 19. Short report: concurrent detection of Trypanosoma cruzi lineages I and II in domestic Triatoma dimidiata from Guatemala.
    Pennington PM, Paiz C, Grajeda LM, Cordón-Rosales C.
    Am J Trop Med Hyg; 2009 Feb 31; 80(2):239-41. PubMed ID: 19190220
    [Abstract] [Full Text] [Related]

  • 20. Risk of Trypanosoma cruzi I (Kinetoplastida: Trypanosomatidae) transmission by Panstrongylus geniculatus (Hemiptera: Reduviidae) in Caracas (Metropolitan District) and neighboring States, Venezuela.
    Carrasco HJ, Torrellas A, García C, Segovia M, Feliciangeli MD.
    Int J Parasitol; 2005 Nov 31; 35(13):1379-84. PubMed ID: 16019006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.